The Rep expression in the mucosa of CRC patients was associated with a CD163+ M2 phenotype (mean 4.5% of all interstitial cells, Fig. 2F) dominating over the M1 phenotype (mean 2.6% of all interstitial cells; the log2‐fold ratio M2/M1 is given in Fig. 2G). This evidence concerns the gene CD163 and colorectal carcinoma.